Assessing the impact of COVID-19 vaccine in human: Bangladesh perspective
Date
2021-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Chattogram Veterinary & Animal |Sciences University
Abstract
COVID-19 disease is caused by the RNA virus SARS-CoV-2. Since it’s emergence, it had a
devastating effect on the entire world claiming so many lives so far. Although preventive
measures implemented, disease spread could not be stopped. Hence vaccinating against the
virus seems to be a valuable option to prevent the disease or at least reduce the intensity of
disease spread. Since vaccines developed in pandemic situations lack adequate trials on
different populations owing to time constraints, the post vaccination adverse effects are still
not well understood. COVISHIELD was the first vaccine administered in Bangladesh. Since
not much is known about the side effects this vaccine can have on the general population of
Bangladesh, this study has been undertaken to identify the various adverse effects of
COVISHIELD in our population as well as to see what risk factors are associated with the
development of COVID-19. This cross-sectional study was conducted between February to
April 2021 in Bangladesh. A questionnaire was developed and distributed through various
platforms on social media. All people who had taken at least one dose of COVISHIELD
vaccine in Bangladesh were requested to fill out the questionnaire. A total of 400 samples were
included in this cases study. More than half the respondents were between 30-50 years age
group (58%), belongs to higher socioeconomic class (50.5%), and were employees at private
firms (51.75%). Significant risk factors associated with development of COVID-19 prior to
vaccination were gender (p=0.013), age (p<0.001), Socioeconomic status (p=0.001),
occupation (p<0.01) and comorbidities like diabetes (p<0.01) and hypertension (p<0.01). The
most common symptom following vaccination was pain at the injection site (n=275) followed
by myalgia (n= 153), lethargy (n= 131), arthralgia (n=119), and fever (n=95). Sickness
following vaccination lasted for less than a week for majority of respondents. Following
vaccination 23 respondents tested positive for COVID-19 with a peak of incidences on the 8th
day post vaccination. Despite the various adverse effects, vaccination against COVID_19 is
strongly recommended since acquiring the disease is far more detrimental.
